Sectors

WST
West Pharmaceutical Services, Inc.
254.80
120 x 248.98
240 x 259.57
bid
ask
+
2.06
0.82%
180 @ 04:00 PM
254.80 +0.00 (0.00%)
Ytd -7.39%
1y 15.03%
249.59
day range
258.24
190.39
52 week range
307.25
Open 250.89 Prev Close 252.74 Low 249.59 High 258.24 Mkt Cap 18.37B
Vol 466.53K Avg Vol 1.00M EPS 6.78 P/E 37.58 Forward P/E 28.78
Beta 1.18 Short Ratio 3.07 Inst. Own 97.72% Dividend 0.88 Div Yield 0.35
Ex Div Date 04-29 Earning 04-23 50-d Avg 243.10 200-d Avg 253.57 1yr Est 316.69
Earning
Date For Estimate Reported Surprise surprise %
2026-04-23 2026-03 1.68 N/A N/A N/A
2026-02-12 2025-12 1.83 2.04 0.21 11.48%
2025-10-23 2025-09 1.67 1.96 0.29 17.37%
2025-07-24 2025-06 1.51 1.84 0.33 21.85%
2025-04-24 2025-03 1.22 1.45 0.23 18.85%
2025-02-13 2024-12 1.75 1.82 0.07 4.00%
Upgrade / Downgrade
Date Firm Action From To
2026-02-13 Barclays Upgrade Equal-Weight Equal-Weight
2026-02-03 Evercore ISI Group Upgrade Outperform Outperform
2025-12-02 Morgan Stanley Upgrade Equal-Weight
2025-10-29 TD Cowen Upgrade Buy
2025-10-27 Barclays Upgrade Equal-Weight Equal-Weight
2025-10-24 UBS Upgrade Buy Buy
Profile
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging products. This segment also provides drug containment solutions in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment primarily serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.
Insider Holder
Date Name Relation Quantity Description
2025-02-17 BIRKETT BERNARD JOHN Chief Financial Officer 7.52K Conversion of Exercise of derivative security
2025-05-05 BUTHMAN MARK A Director 42.86K Stock Award(Grant)
2026-02-17 FAVORITE ANNETTE F Officer 22.34K Conversion of Exercise of derivative security
2025-05-05 FEEHERY WILLIAM F. Director 31.36K Stock Award(Grant)
2026-02-17 GREEN ERIC MARK Chief Executive Officer 175.42K Conversion of Exercise of derivative security
2025-05-05 HOFMANN THOMAS W Director 44.64K Stock Award(Grant)
Institution Ownership
Report Date Organization Position Value Percentage
2025-12-30 Vanguard Group Inc 9.54M 2.43B 13.23%
2025-12-30 Blackrock Inc. 6.60M 1.68B 9.16%
2025-12-30 State Street Corporation 3.25M 828.61M 4.51%
2025-12-30 Artisan Partners Limited Partnership 2.85M 726.28M 3.95%
2025-12-30 Bank Of New York Mellon Corporation 2.66M 678.29M 3.69%
2025-12-30 Brown Advisory Inc. 1.94M 495.23M 2.70%
Fund Ownership
Report Date Organization Position Value Percentage
2025-12-30 VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund 2.26M 577.07M 3.14%
2025-12-30 VANGUARD INDEX FUNDS-Vanguard 500 Index Fund 1.81M 462.38M 2.52%
2025-12-30 VANGUARD INDEX FUNDS-Vanguard Mid-Cap Index Fund 1.57M 398.96M 2.17%
2025-12-30 VANGUARD INDEX FUNDS-Vanguard Growth Index Fund 997.06K 254.05M 1.38%
2026-01-30 iShares Trust-iShares Core S&P 500 ETF 925.78K 235.89M 1.28%
2026-02-27 Fidelity Concord Street Trust-Fidelity 500 Index Fund 915.57K 233.29M 1.27%
Dividend
Dividend Date
0.22 2026-04-29
0.22 2026-01-28
0.22 2025-11-12
0.21 2025-07-30
0.21 2025-04-30
0.21 2025-02-07
Split
Split Date
2 : 1 2013-09-27
2 : 1 2004-09-30
2 : 1 2004-09-29
2 : 1 1987-06-02
2 : 1 1982-05-06